|
Yet another potential indication: Reduction of drug-seeking behavior
|
8
|
Resverlogix Corp.
|
Oct 26, 2021 03:12PM
|
|
Impact factors
|
8
|
Resverlogix Corp.
|
Apr 16, 2019 03:31AM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
8
|
Resverlogix Corp.
|
Nov 29, 2021 05:46PM
|
|
Re: 2% market penetration
|
8
|
Resverlogix Corp.
|
Nov 17, 2017 05:00PM
|
|
Please don't...
|
8
|
Resverlogix Corp.
|
Feb 27, 2017 11:17AM
|
|
BD2 specific inhibitors mentioned in Science
|
9
|
Resverlogix Corp.
|
Mar 22, 2020 06:53AM
|
|
Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
|
9
|
Resverlogix Corp.
|
Dec 16, 2021 02:26PM
|
|
Civil vs. criminal court judgments
|
9
|
Resverlogix Corp.
|
Dec 17, 2019 10:03AM
|
|
IP considerations may prevent RVX from disclosing eGFR data
|
9
|
Resverlogix Corp.
|
Jun 08, 2020 03:35PM
|
|
Re: Their finest hour
|
9
|
Resverlogix Corp.
|
Sep 24, 2019 04:02PM
|
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
9
|
Resverlogix Corp.
|
Jun 06, 2020 02:14PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
9
|
Resverlogix Corp.
|
Nov 29, 2021 06:14PM
|
|
If anyone still cares about science...
|
9
|
Resverlogix Corp.
|
Oct 09, 2020 04:38PM
|
|
Did you know...?
|
10
|
Resverlogix Corp.
|
Jul 05, 2017 04:33PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
10
|
Resverlogix Corp.
|
Oct 14, 2020 03:00PM
|
|
Re: VOLUME
|
10
|
Resverlogix Corp.
|
Jun 30, 2021 06:26AM
|
|
RVX AGM and Zenith AGM, my thoughts
|
10
|
Resverlogix Corp.
|
Sep 12, 2016 05:04PM
|
|
Their finest hour
|
10
|
Resverlogix Corp.
|
Sep 24, 2019 01:31PM
|
|
ABBV-744 is BD2 specific - worth a read
|
10
|
Resverlogix Corp.
|
Feb 02, 2022 03:26PM
|
|
Re: p-values : are correct
|
10
|
Resverlogix Corp.
|
Feb 24, 2017 09:27AM
|
